FR2449093A1 - Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments - Google Patents

Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments

Info

Publication number
FR2449093A1
FR2449093A1 FR8003143A FR8003143A FR2449093A1 FR 2449093 A1 FR2449093 A1 FR 2449093A1 FR 8003143 A FR8003143 A FR 8003143A FR 8003143 A FR8003143 A FR 8003143A FR 2449093 A1 FR2449093 A1 FR 2449093A1
Authority
FR
France
Prior art keywords
preparation
group
cephalosporin derivatives
medicaments
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8003143A
Other languages
English (en)
French (fr)
Other versions
FR2449093B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH154579A external-priority patent/CH641810A5/de
Priority claimed from CH17480A external-priority patent/CH645378A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2449093A1 publication Critical patent/FR2449093A1/fr
Application granted granted Critical
Publication of FR2449093B1 publication Critical patent/FR2449093B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR8003143A 1979-02-16 1980-02-13 Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments Granted FR2449093A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH154579A CH641810A5 (en) 1979-02-16 1979-02-16 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them
CH17480A CH645378A5 (en) 1980-01-10 1980-01-10 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them

Publications (2)

Publication Number Publication Date
FR2449093A1 true FR2449093A1 (fr) 1980-09-12
FR2449093B1 FR2449093B1 (enExample) 1983-07-29

Family

ID=25683752

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8003143A Granted FR2449093A1 (fr) 1979-02-16 1980-02-13 Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments

Country Status (19)

Country Link
US (1) US4477448A (enExample)
AT (1) AT374806B (enExample)
CA (1) CA1161032A (enExample)
DE (1) DE3005012A1 (enExample)
DK (1) DK53780A (enExample)
ES (2) ES488651A0 (enExample)
FI (1) FI800381A7 (enExample)
FR (1) FR2449093A1 (enExample)
GB (2) GB2046734B (enExample)
IE (1) IE49395B1 (enExample)
IL (1) IL59391A (enExample)
IT (1) IT8047922A0 (enExample)
MY (1) MY8500128A (enExample)
NL (1) NL8000894A (enExample)
NZ (1) NZ192873A (enExample)
PH (1) PH17926A (enExample)
PT (1) PT70834A (enExample)
SE (2) SE8000982L (enExample)
YU (1) YU40280A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2498189A1 (fr) * 1981-01-19 1982-07-23 Sandoz Sa Nouveaux derives de l'acide cephalosporanique, leur preparation et leur application comme medicaments
FR2530635A1 (fr) * 1982-07-23 1984-01-27 Servipharm Ltd Composes d'amino-imidazolyle, procede pour leur preparation, preparations pharmaceutiques contenant ces composes, et application de ces dernieres

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037380B1 (en) * 1980-03-28 1984-09-12 BIOCHEMIE Gesellschaft m.b.H. New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
US5688964A (en) * 1996-02-13 1997-11-18 Eastman Kodak Company Process for preparing a acylhyrazino pyrazole derivative
KR100770419B1 (ko) * 1999-09-24 2007-10-26 니혼노야쿠가부시키가이샤 살충, 살진드기제
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2498189A1 (fr) * 1981-01-19 1982-07-23 Sandoz Sa Nouveaux derives de l'acide cephalosporanique, leur preparation et leur application comme medicaments
FR2501685A1 (fr) * 1981-01-19 1982-09-17 Sandoz Sa Nouveaux derives du pyrazole
FR2530635A1 (fr) * 1982-07-23 1984-01-27 Servipharm Ltd Composes d'amino-imidazolyle, procede pour leur preparation, preparations pharmaceutiques contenant ces composes, et application de ces dernieres

Also Published As

Publication number Publication date
AT374806B (de) 1984-06-12
IL59391A0 (en) 1980-05-30
ATA78780A (de) 1983-10-15
IE800284L (en) 1980-08-16
DE3005012A1 (de) 1980-11-27
IL59391A (en) 1983-05-15
US4477448A (en) 1984-10-16
GB2046734B (en) 1983-09-01
PT70834A (en) 1980-03-01
GB2117774B (en) 1984-03-21
PH17926A (en) 1985-01-31
ES8102134A1 (es) 1980-12-16
NZ192873A (en) 1984-07-31
FR2449093B1 (enExample) 1983-07-29
NL8000894A (nl) 1980-08-19
CA1161032A (en) 1984-01-24
GB2117774A (en) 1983-10-19
IT8047922A0 (it) 1980-02-15
YU40280A (en) 1983-06-30
ES497002A0 (es) 1982-04-01
FI800381A7 (fi) 1981-01-01
ES8203848A1 (es) 1982-04-01
DK53780A (da) 1980-08-17
GB8309730D0 (en) 1983-05-18
GB2046734A (en) 1980-11-19
IE49395B1 (en) 1985-10-02
ES488651A0 (es) 1980-12-16
SE8000982L (sv) 1980-08-17
SE8500589D0 (sv) 1985-02-08
MY8500128A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
FR2439182A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2449093A1 (fr) Nouveaux derives de la cephalosporine, leur preparation et leur application comme medicaments
BE843140A (fr) Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
BE868796A (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
LU79294A1 (fr) Procede pour la preparation de nouveaux derives de la morphine et application a titre de medicament
FR2392991A1 (fr) Nouvelles 5,11-dihydro-6h-pyrido(2,3-b) (1,4) benzodiazepin-6-ones substituees en position 11, procedes pour leur preparation et medicaments renfermant ces composes
FR2392993A1 (fr) Nouvelles 5,11-dihydro-6h-pyrido(2,3-b) (1,4) benzadiazepin-6-ones, procedes pour leur preparation et medicaments renfermant ces composes
FR2417502A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
BE869133A (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2392992A1 (fr) Nouvelles 5,11-dihydro-6h-pyrido(2,3-b) (1,4) benzodiazepin-6-ones substituees en position 11, procedes pour leur preparation et medicaments renfermant ces composes
FR2456104A1 (fr) Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
BE866911A (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur preparation
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2390424A1 (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur application
BE792515A (fr) Nouveaux derives de l'acide lysergique, leur preparation et leur application comme medicaments
FR2335222A1 (fr) Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant
BE860162A (fr) Derives actifs de l'uree leur procede de preparation ainsi que les compositions therapeutiques les contenant
FR2397418A1 (fr) Esters de penicilline utilisables comme medicaments et procede pour leur preparation
BE884716A (fr) Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes
FR2336134A1 (fr) Derives trifluoromethylthio de cyproheptadine utiles comme medicament
IE790754L (en) Substituted ethanolamines
FR2368490A1 (fr) Nouveaux derives de l'acide clavulanique, leur preparation et compositions pharmaceutiques en contenant
BE863802A (fr) Nouveaux derives d'everninomicine, leur procedes de preparation et compositions pharmaceutiques contenant lesdits derives
BE859084A (fr) Nouveaux derives de l'imidazo (5,1-a)isoquinoleine, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse